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Abstract
Gene deletion and protein expression are cornerstone procedures for studying metabolism in any 
organism, including methane-producing archaea (methanogens). Methanogens produce coenzymes 
and cofactors not found in most bacteria, therefore it is sometimes necessary to express and purify 
methanogen proteins from the natural host. Protein expression in the native organism is also useful 
when studying post-translational modifications and their effect on gene expression or enzyme 
activity. We have created several new suicide plasmids to complement existing genetic tools for 
use in the methanogen, Methanosarcina acetivorans. The new plasmids are derived from the 
commercially available E. coli plasmid, pNEB193, and cannot replicate autonomously in 
methanogens. The designed plasmids facilitate markerless gene deletion, gene transcription, 
protein expression, and purification of proteins with cleavable affinity tags from the methanogen, 
Methanosarcina acetivorans.
1. Introduction
Genetic methods for Methanosarcina species are well developed, and making mutations on 
the chromosome is a routine procedure in several laboratories [1–5]. We sought to increase 
the ease-of-use for these tools to facilitate cloning, protein expression, and molecular 
biology experiments. The plasmid tools we have created complement existing methods and 
expand the repertoire of in vivo experiments possible in methanogens. Of particular need is 
the ability to express tagged proteins in methanogens to facilitate protein purification from 
the native host.
Methanogens survive by reducing carbon substrates to methane gas in a process called 
methanogenesis [6]. They employ unique enzymes and cofactors to activate carbon for 
reduction, and simultaneously generate a transmembrane ion gradient that is used for ATP 
synthesis [7, 8]. Unusual cofactors used in methanogens include coenzyme M, coenzyme B, 
methanopterins, methanophenazine, dimethylbenzimidazolyl cobamide, and deazaflavin 
F420 [9–25]. Because of these unusual cofactors, it may be difficult or impossible to express 
some methanogen proteins in heterologous hosts that do not produce these cofactors. If 
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cofactor binding is essential for proper protein folding, the absence of the cofactor may 
result in misfolded and/or insoluble protein. If the protein does fold properly in a 
heterologous host, it is possible that host cofactors may bind in the active site in place of the 
native cofactor. For instance, dimethylbenzimidazolyl cobamide is structurally similar, 
though not identical to cobalamin [26–28]. The methanogen methanol:corrinoid 
methyltransferase, MtaB, and the corrinoid protein, MtaC, from Methanosarcina barkeri, 
have been purified from E. coli and biochemically characterized [29–31]. MtaB and MtaC 
expressed in E. coli are insoluble, and must be refolded in vitro after purification. As a 
result, MtaC is devoid of cofactor and must be reconstituted with the non-native corrin 
cofactor, hydroxycobalamin. While heterologously expressed, refolded, and reconstituted 
protein can be suitable for biochemical characterization, these treatments introduce the 
possibility of producing structural artefacts that can inhibit crystal formation. As such, 
overexpression of proteins in the native organism can be desirable to purify soluble protein 
populated with the biologically relevant cofactor. The crystal structure of the MtaBC 
complex was successfully obtained using protein purified from M. barkeri [32].
Dimethylbenzimidazolyl cobamide is not the only exotic cofactor found in methanogens. 
Coenzyme F420 is a deazaflavin, and structurally similar to flavin mononucleotide (FMN) in 
E. coli [19, 33–36]. To our knowledge, no predicted flavin-binding proteins from 
methanogens has been heterologously expressed or crystallized to date. One reason for the 
paucity of methanogen flavoprotein structures could perhaps be because annotated flavin 
adenine dinucleotide (FAD) or FMN binding sites may in fact be F420 binding sites. 
Therefore E. coli flavins may not be able to bind correctly in F420 binding site, resulting in 
unstable or misfolded protein. Methanogens also express many proteins with catalytic or 
structural iron/sulfur clusters, which do not have homologs in E. coli [37–45]. Therefore, 
expression of iron/sulfur cluster proteins in E. coli runs the risk of producing insoluble or 
misfolded protein, which may or may not be able to be reconstituted in vitro with Fe2+ and 
S2− [46].
Several methanogen proteins which do not require cofactors have been successfully 
expressed from E. coli, such as histone-like proteins, glutamine synthetase GlnK, and 
CRISPR Cas6 [47–50]. However, in some circumstances though proteins are not anticipated 
to require a cofactor or iron/sulfur cluster, expression of methanogen proteins in E. coli can 
still be challenging due to differences in codon usage between the two organisms [51–54]. 
Codon usage is significantly different between E. coli and methanogens. Translation of 
methanogen proteins can be accomplished using E. coli expression strains engineered to 
produce rare codons, however the yields can be low [55–57]. The yield of heterologously 
expressed methanogen protein can be increased by codon optimizing the nucleotide 
sequence for E. coli [55, 57]. Synthesis of codon-optimized genes is more expensive than 
traditional cloning involving PCR amplification of the gene of interest. Taking into account 
the high proportion of methanogen proteins with iron/sulfur clusters and unique cofactors, 
we perceived a need for a wider array of molecular tools for protein expression and 
purification in methanogens.
To address the need for plasmids that can be used to express and purify protein from 
methanogens, we designed new suicide plasmids based on the features of pMP44 and 
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pJK026A [58, 59]. pMP44 is useful for markerless deletion of genes using homologous 
recombination [58]. However, pMP44 replicates in the E. coli host at a relatively low-copy 
number and must be propagated in a pir+ strain [60, 61]. Plasmid pJK026A and its 
derivatives can be used for inserting DNA at a ϕC31 phage att site which has been added to 
the chromosome [59]. It is useful for expressing protein in Methanosarcina, or for studying 
transcription and translational fusions [2]. pJK026A family plasmids are 11.7 Kb, and must 
be purified from a trfA+ E. coli strain [62]. The plasmid sizes, low copy number, and need 
for separate E. coli host strains, are attributes that can present technical challenges during 
cloning. We wanted to determine if the features of pMP44 and pJK026A could be used to 
create smaller plasmids that are suitable for high-copy replication in DH5α or DH10β E. coli 
hosts. The new suicide plasmids are designed to 1) use conventional, commercially-available 
E. coli hosts, 2) simplify and speed up the cloning process, and 3) combine features in a 
multifunctional plasmid that can stably integrate onto the M. acetivorans chromosome and 
be used for in vivo protein expression and purification via Strep-Tag II and histidine affinity 
tags [63–65].
2. Materials and Methods
2.1 Growth of cultures
E. coli was grown in Lysis Broth (LB) at 37°C with shaking [66]. M. acetivorans strains 
were grown at 35°C in HS medium as described [67]. Table 1 lists all the E. coli and M. 
acetivorans strains used in this study. The following additions were added as required (final 
concentration): ampicillin (100 µg ml−1), kanamycin (50 µg ml−1), chloramphenicol (8 or 35 
µg ml−1), rhamnose (10 mM), histidine (0.1 mM), puromycin (2 µg ml−1), 8-aza-
diaminopurine (8-ADP) (20 µg ml−1), trimethylamine (50 mM), methanol (125 mM), and 
acetate (40 or 120 mM).
2.2 DNA techniques and cloning procedures
PCR Primers and DNA sequences in Table 2 were designed using Vector NTI software (Life 
Technologies Corporation, Grand Island, NY). Genes, oligos, and multiple cloning sites 
were synthesized commercially by Integrated DNA Technologies (IDT, Coralville, IA) and 
Life Technologies Corporation (Grand Island, NY). Various PCR techniques were employed 
during the course of this work, including overlap extension and site-directed mutagenesis 
[68, 69]. For all PCR amplifications, Phusion Flash PCR Master Mix was used as a source 
of proofreading DNA polymerase (Life Technologies Corporation (Grand Island, NY)). 
DNA purification was carried out using Wizard kits from Promega (Madison, WI). DNA 
fragments were joined using T4 DNA ligase (New England Biolabs, Ipswich, MA) or 
GeneArt kits (Life Technologies Corporation (Grand Island, NY)). Restriction enzymes 
(AscI, BamHI, NdeI, NcoI, EcoRI, SphI, XbaI) were purchased from New England Biolabs 
(Ipswich, MA). All plasmids were sequenced by Eurofins Operon MWG (Huntsville, AL).
2.3 Transformation
Plasmids used and created in this study are listed in Table 3. E. coli was transformed by 
electroporation and plated onto LB agar plates (1.5% w/v agar) containing the appropriate 
antibiotic [70]. M. acetivorans was transformed using the liposome-mediated transformation 
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method [71]. After transformation and recovery, M. acetivorans cells were plated on HS 
medium with 50 mM trimethylamine as carbon source solidified with 1.4% agar and 
incubated in Wolfe incubators (Coy Laboratory Products, Grass Lake, MI) under premixed 
20% CO2/79.9% N2/0.1% H2S atmosphere (Matheson).
2.4 Western Blot Analysis
Sample protein concentration was determined using the Coomassie Plus Protein Assay 
Reagent (Life Technologies Corporation (Grand Island, NY)). Samples were diluted with 6X 
Cracking Buffer (348 mM Tris pH 6.8, 349 mM SDS, 600 mM DTT, 4.1 mM glycerol, 180 
µM bromophenol blue), boiled for 10 minutes, and 2 µg each sample were loaded per lane 
on a 12% sodium dodecyl sulfate-polyacrylamide gel (Bio-Rad, Hercules, CA). Three 
microliters of Precision Plus Protein Dual Color Standards (Bio-Rad, Hercules, CA) and 1.5 
µL of Precision Plus Protein WesternC Standards (Bio-Rad, Hercules, CA) were used as 
markers. Proteins were separated at 15 mA per gel for 30 minutes and 30 mA per gel for 45 
minutes. Proteins were transferred to a polyvinylidene difluoride membrane (PVDF) (Bio-
Rad, Hercules, CA) for 1 hour at 100 V in transfer buffer (25 mM Tris, 192 mM glycine, 
15% methanol). The membrane was blocked with 25 mL 5% nonfat dry milk in Tris-
buffered saline (137 mM NaCl, 20 mM Tris pH 7.6) with 0.1% TWEEN 20 (TBST) 
overnight and probed with a 1:4000 dilution of Strep-Tag II Antibody, HRP Conjugate 
(Novagen, EMD Millipore, Temecula, CA) in 20 mL of Blocking Solution. Strep-tagged 
protein was detected with Pierce ECL Western Blotting Substrate (Life Technologies 
Corporation (Grand Island, NY)).
2.5 β-glucuronidase enzyme assays
Cell extract was assayed for β-glucuronidase activity as described [59]. Briefly, 10 ml 
exponential phase cultures of strains listed in Table 1 were harvested by centrifugation in a 
TX-750 Swinging Bucket Rotor with 15 mL conical tube adapters at 4031 × g for 3 minutes 
at room temperature. Cells were resuspended in 200 µl of 50 mM Tris-Cl, 1 mM DTT pH 
8.0 buffer, followed by the addition of 1 u of DNaseI (Life Technologies Corporation (Grand 
Island, NY)) and Halt Protease Inhibitor Cocktail, EDTA-Free (Life Technologies 
Corporation (Grand Island, NY)) to a final concentration of 1X. Cells were lysed on ice for 
10 minutes, and insoluble cell debris was removed by centrifugation in F21–48×1.5/2.0 rotor 
at 14000 × g for 10 minutes at room temperature. Cleavage of p-nitrophenyl glucuronide to 
p-nitrophenol was detected by increased absorbance at 415 nm in a Tecan Sunrise plate 
spectrophotometer (Tecan US, Inc., Morrisville NC). The extinction coefficient of p-
nitrophenol was determined in Solid 96 Well Plates (Fisher catalog #21-377-205) with a 
path length of 0.5 cm at 415 nm. Protein concentration was measured using the Coomassie 
Plus Protein Assay Reagent (Life Technologies Corporation (Grand Island, NY)).
3. Results
3.1 pNB723 plasmid design
We created a high-copy plasmid, pNB723, for markerless deletion of Methanosarcina genes 
to circumvent the need to use pir+ E. coli hosts (Figures 1 and S1). To construct pNB723, we 
used pNEB193 as the E. coli plasmid scaffold (New England Biolabs, Ipswich, MA). 
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pNEB193 is a small, high-copy, commercially available vector with a pUC19 origin of 
replication, a bleomycin (ampicillin) resistance cassette, and a PT7 lacZ cassette for blue-
white selection of plasmids containing inserts at the multiple cloning site. To select 
Methanosarcina strains which have recombined the plasmid onto the chromosome, we added 
the pac (puromycin acetyltransferase) gene at the unique XbaI and SphI restriction sites on 
pNEB193. We optimized the pac codons for expression in Methanosarcina, thereby lowering 
the %GC content from 73.1% to 48.5%, and eliminating interference in sequencing reactions 
that can occur when plasmids contain high %GC stretches (Figure S2). The optimized pac 
gene was amplified from pMS86 using oligos oNB115 and oNB116, which added a XbaI 
restriction site at the 5’ end of the gene, and tandem SpeI and SphI restriction sites at the 3’ 
end of the gene. The resulting plasmid carrying a promotorless optimized pac gene is 
pNB721.
The Methanococcus voltae PmcrB promoter from pMP44 was cloned upstream of the pac 
gene at the XbaI restriction site, creating plasmid pNB722. The PmcrB(M. voltae) promoter 
will constitutively express the pac gene in Methanosarcinales. PmcrB(M. voltae) was cloned 
from pMP44 using oligos oNB128 and oNB129, which added XbaI sites at each end of the 
gene. Orientation of the promoter was verified by DNA sequencing to ensure that the pac 
gene will be expressed in the host strain.
Finally, we cloned a hypoxanthine phosphoribosyltransferase gene (hpt) at the SpeI and SphI 
restriction sites in pNB722 so that the resulting plasmid, pNB723, expresses the hpt gene in 
an operon with the pac gene. The hpt gene is a counterselection marker that can be used to 
create a markerless gene deletion when transformants are plated on the purine analog, 8-aza-
diaminopurine (8-ADP) [58]. The hpt gene was also codon-optimized for expression in 
Methanosarcina, which resulted in lowering the %GC content from 47.6% to 36.7% (Figure 
S3). The optimized hpt gene was amplified from pMS66 using oligos oNB106 and oNB127, 
which added a XbaI site at the 5’ and at the 3’ ends of the gene. Directionality of the hpt 
gene was verified by DNA sequencing. The resulting pNB723 plasmid has unique NdeI and 
BamHI sites, and two AscI restriction sites, which can be used to clone DNA sequences for 
deletion of genes in Methanosarcina.
3.2 Deletion of MA4421 using pNB723
To demonstrate that pNB723 functions as designed, we used it to delete the MA4421 prenyl 
reductase gene from the M. acetivorans chromosome (Figure 2). For the plasmid validation 
purposes here, the gene to be deleted was expected to be nonessential. The DNA sequence 5’ 
upstream of the MA4421 gene was amplified using primers oNB250 and oNB252. The 3’ 
downstream DNA sequence was amplified using primers oNB251 and oNB253. The 5’ and 
3’ sequences were fused using oligos oNB311 and oNB312, and cloned into the pNB723 
plasmid at the AscI restriction site, resulting in plasmid pALD1 (Figure S4). Plasmid 
pALD1 was transformed into M. acetivorans strain NB34 using liposomes, and puromycin 
as a selection agent. The puromycin-resistant colonies were streaked for isolation, grown in 
liquid medium without puromycin, and plated onto agar containing 8-ADP to counterselect 
for the hpt gene. The resulting 8-ADP-resistant colonies were streaked for isolation, and 
grown in liquid medium without puromycin or 8-ADP. Markerless deletion of the MA4421 
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gene was confirmed by PCR amplifying the MA4421 deletion junctions from genomic DNA 
using the oNB274, oNB318 and oNB319 oligos (Figure 2). In this PCR strategy, the 
screening oligos do not anneal to the 5’ upstream or 3’ downstream DNA sequences that 
were used to construct the pALD1 deletion plasmid. Methanosarcina cells can carry several 
copies of the chromosome, and PCR amplification for the deleted gene is essential to ensure 
that all copies of the gene have been deleted [72]. In addition, plasmids may integrate in 
unpredictable ways if there is a region of low complexity or if the gene is essential. 
Surviving cells may, for instance, create large deletions, amplifications, or insertions to 
preserve essential gene function while also generating a false-positive in a PCR screen. As 
additional measures to confirm strain identity, genome resequencing and/or Southern blots 
using probes specific for the deleted gene, for flanking genomic regions, or for pac or bla (to 
verify plasmid insertion at the expected location) is also indicated (Figure S5).
3.3 pNB730 plasmid design
We created a pNEB193-derived plasmid for expression of tagged protein in Methanosarcina. 
Using oligos oNB151 and oNB152, we removed the SpeI restriction site, creating plasmid 
pNB724. pNB724 was amplified using oligos oNB110 and oNB111, which creates SpeI 
restriction sites at the 5’ and 3’ ends of the linear amplification product. To insert the ϕC31 
phage attB attachment site that allows the plasmid to recombine with the ϕC31 attP site on 
the M. acetivorans NB34 chromosome, we amplified the ϕC31 phage attB site from 
pJK026A using oligos oNB117 and oNB118, which creates XbaI restriction sites at the 5’ 
and 3’ ends of the amplification product. The XbaI-digested attB fragment was ligated into 
the SpeI-digested pNB724 amplicon to create pNB727. pNB727 was verified by DNA 
sequencing.
Next, we designed an expression cassette with multiple restriction sites to facilitate cloning 
(Figure 3). The cassette, encoded on plasmid pNB716, contains the PmcrB promoter from 
pJK026A and a multiple cloning site (MCS) flanked by sequences encoding the Strep-Tag II 
peptide (strep, WSHPQFEK) and histidine tags (his, HHHHHHHH). The Strep-Tag II 
peptide was codon optimized for expression in M. acetivorans (Figure 3, orange shaded 
sequences). The 5’ and 3’ tag sequences were not identical so as to prevent homologous 
recombination that would result in loss of the MCS or of the gene to be expressed. The 
expression cassette was designed such that cloning a gene into the NdeI site results in 
expression of native protein. Cloning the gene into the NcoI site results in protein with an 
amino-terminal his-strep tag. Carboxy-tagged protein can be expressed by removing the stop 
codon from the gene and cloning into the BamHI, ApaI, or NruI restriction sites. Therefore 
this expression cassette can be used to express native, amino-tagged, carboxy-tagged, or 
dual-tagged protein depending on the restriction sites used. A strong translational stop signal 
was added after the 3’ his-strep tag sequence by introducing four stop codons within a 20 bp 
region. The expression cassette was amplified from pNB716 using oligos oNB183 and 
oNB184 and digested with XbaI restriction enzyme.
pNB727 was amplified using oligos oNB130 and oNB131, resulting in a linearized 
amplicon containing SpeI restriction sites at the 5’ and 3’ termini. The pNB727 amplicon 
was digested with SpeI, then ligated with the XbaI-digested expression cassette from 
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pNB716, to create the plasmid pNB729. Finally, oligos oNB185 and oNB186 were used to 
amplify pNB729 and remove the BamHI restriction site upstream of the pac expression 
cassette. The resulting plasmid, pNB730, contains unique NdeI, NcoI, BamHI, ApaI, and 
NruI restriction sites for cloning genes into the expression cassette multiple cloning site. 
pNB730 was verified by DNA sequencing (Figure S6).
3.4 Native and tagged expression of uidA using pNB730
We used the β-glucuronidase (uidA) gene to measure tagged and untagged protein 
expression in M. acetivorans from the expression cassette we created (Figure 4). The uidA 
gene was amplified from pJK026A using oligos oNB369 and oNB371 and cloned into the 
NdeI and BamHI sites of pNB730 to create plasmid pSK1 (expresses native UidA) (Figure 
S7). The uidA gene was also amplified from pJK026A using oligos oNB370 and oNB372, 
and cloned into the NcoI and BamHI sites to create plasmid pSK2 (expresses dual-tagged 
UidA) (Figure S8). Plasmids pSK1 and pSK2 were transformed into M. acetivorans strain 
NB34. Cells which had recombined the plasmid onto the chromosome at the ϕC31 attP site 
were selected using puromycin. Puromycin-resistant colonies were streaked for isolation, 
grown in liquid medium without antibiotic, and screened by PCR.
To screen for integration at the attP site, oligos “C31 screen-all#1”, “C31 screen C2A #1”, 
“C31 screen pJK200#1”, and oNB317 were used in a four-oligo PCR reaction with genomic 
DNA [59]. In this four-oligo PCR amplification, genomic DNA from strains which have 
integrated a single copy of pNB730-derived plasmids will produce amplicons of 740 and 
471 bp. A 301bp band is amplified by plasmid alone or if multiple copies of the pNB730-
derived plasmid has integrated at the ϕC31 attP site. Parental genomic DNA template will 
result in amplification of a 910 bp fragment. Using this screen, we verified the creation of 
strains NB231 (Δhpt::ϕC31 int, att:pSK1) and NB232 (Δhpt::ϕC31 int, att:pSK2), which had 
recombined the respective plasmid at the ϕC31 attP site on the chromosome. Plasmid 
integration was also confirmed by Southern blot using the uidA gene as a probe (Figure S9).
Next, we verified expression of UidA enzyme from the integrated pSK1 or pSK2 plasmids 
(Figure 4). To verify expression of tagged protein, we analyzed cell extract from strains 
NB231 (att:pSK1), NB232 (att:pSK2) by Western blot using anti-strep-tag antibodies. The 
parent extract was used as a negative control, and the positive control was cell extract from 
strain NB75, which expresses strepHdrD2 (37 kDa) from an integrated copy of the 
pJK026A-derived plasmid, pNB665. The cell extract from strains that expressed tagged 
protein had a single strep-tagged protein band at the expected size of 71 kDa, whereas the 
parent extract and NB231 (att:pSK1, which expresses untagged UidA protein), had no 
visible bands. We also added 0.1 mM histidine to cultures to determine if adding exogenous 
histidine to the medium could increase expression of his-tagged protein. It would be 
reasonable to hypothesize that methanogens may produce limiting quantities histidine to 
synthesize large quantities of a his-tagged protein. Histidine supplementation, assuming it 
could be transported into the cell and used to charge histinyl tRNAs, may alleviate this 
limitation and result in higher expression levels. However, addition of histidine had no 
measurable effect on protein expression. Finally, we verified that the UidA protein expressed 
from pNB730 was properly folded and active. As expected, cell extract from strains NB231 
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(att:pSK1, expresses untagged protein) and NB232 (att:pSK2, expresses dual-tagged 
protein) had detectable β-glucuronidase activity, whereas extract from the parent strain had 
no detectable β-glucuronidase activity (Figure 4). We noted that activity of untagged β-
glucuronidase (pSK1) is higher than the dual-tagged β-glucuronidase (pSK2), demonstrating 
that amino and/or carboxy-terminal peptide tags can affect enzyme function and may not 
reflect differences in translation efficiency from identical promoters.
3.5 Creation of plasmids for expression of protein with cleavable affinity tags
In some circumstances (i.e., if it interferes with enzyme activity, or for protein 
crystallography) it may be preferable to have the ability to cleave affinity tags from 
expressed protein. Therefore we designed two additional plasmids based on pNB730, which 
include thrombin cleavage sites (Figure 2). The thrombin recognition site (LVPRGS) was 
optimized for expression in M. acetivorans [73, 74]. Plasmid pNB735 has the thrombin site 
immediately downstream of the 5’ strep-tag and histidine tag, before the NcoI site where a 
gene of interest can be cloned. The complementary plasmid, pNB737, was created to express 
proteins with a thrombin-cleavable amino-terminal his tag. The sequences of both plasmids, 
pNB735 (Figure S10) and pNB737 (Figure S11), have been verified by DNA sequencing.
4. Discussion
We have succeeded in creating a suite of easy-to-use plasmids for gene deletion and 
expression of affinity tagged protein in Methanosarcina acetivorans. We have also 
demonstrated the utility of these plasmids in deleting genes from the chromosome 
(MA4421), and in expressing active enzymes in vivo. Depending on the restriction sites used 
for insertion of the gene of interest, the expressed protein either contains Strep-Tag II and 
histidine affinity tags or is untagged. The small, high-copy plasmids are compatible with 
ligation-independent cloning methods such as GeneArt Seamless Cloning and Assembly 
Kits (Invitrogen). The ease of propagation in E. coli, and the ease of cloning make the 
pNB723 and pNB730 family plasmids compatible with modern synthetic biology 
experiments. Though not demonstrated in this work,, plasmid pNB730 can be used for a 
wide array of experiments including mutant complementation, purification of proteins to 
study post-translational modification, and metabolic engineering applications in addition to 
expression of foreign proteins in the cell [75–77].
pNB735 and pNB737 plasmids will also make it easier to express protein in Methanosarcina 
for purification and crystallography purposes. To advance methanogen structure/function 
studies, we anticipate plasmid tools designed specifically for protein purification in 
methanogens, such as pNB735 and pNB737, may make it possible to obtain large quantities 
of pure, correctly folded protein from the native organism. Purification of protein from the 
native host may enable correct protein folding and population of the active site with the 
physiological cofactor. After purification, affinity tags can be removed by digestion with 
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thrombin protease. The pNEB193-derived plasmids we created add to the expanding 
repertoire of genetic and protein expression tools in M. acetivorans and other 
Methanosarcina species [5, 58, 59, 78, 79].
The multiple cloning site we designed for pNB730 and derivative plasmids contained a UAG 
stop codon to terminate translation of the carboxy-terminal his-strep affinity tag. In 
Methanosarcina, UAG can either be translated as a pyrrolysine residue, or will be recognized 
as a termination signal, depending on whether a PYLIS element is encoded in the 3’ 
untranslated region of the RNA. When a PYLIS element is absent, approximately 70% of 
the translated polypeptides will stop at the UAG, while 30% of the time pyrrolysine will be 
incorporated into the growing protein chain, and translation continues until a second UAA or 
UGA stop codon is encountered. In the pNB730 multiple cloning site, the next in-frame stop 
codon is 336 bp downstream. If pyrrolysine had been incorporated in the uidA translation 
product, we would expect to detect two bands, one at 71 kDa, and the pyrrolysine read-
through product at 83 kDa. In anti-strep immunoblots we only detected a single band at 71 
kDa, indicating that translation was terminated at the first UAG codon. Kryzcki and 
coworkers noted that in highly expressed monomethylamine methyltransferase genes, the +1 
and +2 nucleotides after the pyrrolysine-coding UAG codon are often GG [80]. Others have 
observed that the efficiency of pyl incorporation at UAG codons in heterologous systems can 
vary with the gene context [81, 82]. This contextual dependence on translational termination 
has been described in eukarya [83]. Our data suggests that the +1 and +2 nucleotides after 
the stop codon, TT, may disfavor pyrrolysine incorporation and instead results in translation 
termination in methanogens.
5. Conclusions
Methanogenic archaea produce several unusual coenzymes and cofactors that are not 
synthesized by E. coli, thereby constraining the ability to use E. coli as a heterologous host 
for overexpression and purification of a subset of methanogen proteins. To address this 
limitation, we have created a suite of plasmids for gene deletion and protein overexpression 
in Methanosarcina species. The new plasmids are derived from the small, high-copy E. coli 
plasmid, pNEB193, and can be propagated in standard E. coli cloning strains. We have 
successfully used the new plasmids to overexpress a native or his-strep tagged β-
glucuronidase and to delete the gene MA4421 from the chromosome. These plasmids 
complement the growing list of genetic tools available for studying methanogen biology, and 
will be especially useful for identifying post-translational modifications in methanogen 
proteins, and for expressing proteins with amino- or carboxy-terminal affinity tags that can 
be cleaved with thrombin.
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Highlights
• We have created a suite of user-friendly plasmids for methanogens.
• The new plasmids are now compatible with ligation-independent cloning.
• We validated plasmids for markerless gene deletion
• Plasmids were used to express a native and his-tagged reporter gene.
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Figure 1. 
pNB723 and pNB730 plasmid maps. Genes encoding puromycin acetyltransferase (pac, red) 
and hypoxanthine phosphoribosyltransferase (hpt, green) are codon-optimized for 
expression in Methanosarcina.
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Figure 2. 
Deletion of MA4421 from the chromosome using pALD1. Schematics of the MA4421 
genomic locus in the parental strain (A), and in the deletion mutant (B), are shown. (C) PCR 
results with oligos oNB274 and oNB319 showing deletion of MA4421 in two isogenic 
isolates. Gray box= MA4421 coding sequence. White boxes= DNA sequences upstream 
(“up”) and downstream (“down”) of the MA4421 gene that were used to create plasmid 
pALD1. Open arrowheads= annealing site of PCR oligos used to construct pALD1. Solid 
arrowheads= annealing site of PCR oligos used to screen for deletion of MA4421 on the 
chromosome. M= DNA size marker. Kb= kilobasepairs. The asterisks denote the expected 
amplicon sizes.
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Figure 3. 
Multiple cloning sites of pNEB193-derived plasmids used for protein expression in 
Methanosarcina. The ribosome binding site is in bold font. Unique restriction sites are 
underlined. Green triangle= translation start site. Red square= stop codon. Orange box= 
Strep-Tag II sequence. Blue box= histidine tag sequence. Gray box= thrombin recognition 
sequence.
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Figure 4. 
Expression of tagged UidA protein in M. acetivorans. (A) Verification of integration of 
pSK1 and pSK2 on the chromosome. Genomic DNA from four isolates of each 
transformation were screened by PCR. M= marker. (B) Western blot of strep-his-UidA-his-
strep protein expressed in M. acetivorans. Two micrograms of total protein from each strain 
were separated by denaturing PAGE. Western blots were probed with anti-strep antibodies. 
His= cultures were supplemented with 0.1 mM histidine. (C) Triplicate cultures of each 
strain were assayed in triplicate (N=9). Specific activity reported in nmoles min−1 mg−1 
lysate.
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Table 1
Strains used in this study
NB# Genotype Purpose Reference
E. coli strains
NB3 5α F' lacIq parent New England Biolabs
NB4 10β parent New England Biolabs
NB100 10β/pNB721 Promotorless pac (opt) for conditional essentiality test of promoters in 
M. acetivorans
This study
NB101 10β/pNB722 pac (opt) vector for homologous recombination repair of mutants, gene 
deletion by homologous recombination (marked) in M. acetivorans
This study
NB104 5α F' lacIq/pNB723 Gene deletion by homologous recombination (markerless) in M. 
acetivorans
This study
NB128 5α F' lacIq/pNB724 pac (opt) vector for homologous recombination repair of mutants, gene 
deletion by homologous recombination (marked) (unique SpeI restriction 
site) in M. acetivorans
This study
NB131 5α F' lacIq/pNB727 operon insertion into ϕC31 attP site on the chromosome in M. 
acetivorans
This study
NB133 5α F' lacIq/pNB729 Expression of native or tagged protein in M. acetivorans This study
NB134 5α F' lacIq/pNB730 Expression of native or tagged protein (unique BamHI restriction site) in 
M. acetivorans
This study
NB161 5α F' lacIq/pALD1 MA4421 deletion by homologous recombination (markerless) in M. 
acetivorans
This study
NB224 5α F' lacIq/pSK1 Expresses native UidA in M. acetivorans This study
NB225 5α F' lacIq/pSK2 Expresses strep-his-UidA-his-strep protein in M. acetivorans This study
NB238 10β / pNB735 Expresses native or tagged protein in M. acetivorans. Amino-terminal 
strep-his tag is cleavable with thrombin protease.
This study
NB239 10β/ pNB737 Expresses native or tagged protein in M. acetivorans. Amino-terminal his 
tag is cleavable with thrombin protease.
This study
M. acetivorans strains
NB34 Δhpt::ϕC31 int, attP parent [59]
NB218 Δhpt::ϕC31 int, attP, ΔMA4421 ΔMA4421 mutant This study
NB231 Δhpt::ϕC31 int, att:pSK1 Expresses native UidA protein This study
NB232 Δhpt::ϕC31 int, att:pSK2 Expresses strep-his-UidA-his-strep tagged protein This study
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Table 2
Sequences of DNA synthesized in this study
Purpose Name Sequence (5’-3’) Reference
Amplify pac (opt) gene from 
pMS86
oNB115 TCTAGAGTGATTCTCATGACCGAATATAAAC This study
oNB116 GCATGCACTAGTTCATGCTCCAGGTTTCCTG This study
Amplify PmcrB(M. voltae) from 
pMP44
oNB128 ACTAGTCGGTTTGCGTATTGGCG This study
oNB129 ACTAGTTCCTATTTTTTTGATATATACATCATAACA This study
Amplify hpt (opt) from pMS66 oNB106 TCTAGATCACTGATTTCCAAAAACATCTTTAATCTCAACTCC This study
oNB127 TCTAGACATGGTTGAAAGGCTTAAAGATTCCC This study
Removes SpeI restriction site from 
pNB722
oNB151 GCATGCAAGCTTGGCGTAATCATG This study
oNB152 GCATGCTCATGCTCCAGGTTTCC This study
Amplify ϕC31 attB from 
pJK026A
oNB117 TCTAGAATGAATCAACAACTCTCCTGGCGCA This study
oNB118 TCTAGACGCTGGCGATTCAGGTTCATCATG This study
Amplify entire pNB724 oNB110 ACTAGTCTTGTCTGCTCCCGGCATCCG This study
oNB111 ACTAGTCCCGTCAGGGCGCGTCA This study
Amplify entire pNB727 oNB130 ACTAGTGGTGTGAAATACCGCACAGATGCGTAA This study
oNB131 ACTAGTTGACGCGCCCTGACGGG This study
Amplify expression cassette from 
pNB716 (inserts in pIDTSmart-
Amp)
oNB183, M13 forward 
- 20
GTGTAAAACGACGGCCAGTTTATCTAGTCA Integrated 
DNA 
Technolog 
ies (IDT)
oNB184, M13 reverse 
-27
CCTCAGGAAACAGCTATGACATCAAGCT Integrated 
DNA 
Technolog 
ies (IDT)
Removes second BamHI site from 
pNB729
oNB185 GGGGGCGCGCCGGATCTTAATTAAGTCTAG This study
oNB186 CTAGACTTAATTAAGATCCGGCGCGCCCCC This study
Creation of MA4421 deletion 
fusion fragment
oNB250 AAAAAAAAAAAAGGCGCGCCCTGGATTTTTTACAGATTCTAATGATTCCAGG This study
oNB251 GCTCTGCATATATCTTGGATCTTATACCCCATGCTGAACTACAGAACGTT This study
oNB252 AACGTTCTGTAGTTCAGCATGGGGTATAAGATCCAAGATATATGCAGAGC This study
oNB253 AAAAAAAAAAAAGGCGCGCCCCTGCCCCTCACATAATCGTGC This study
oNB311 GCCCTGGTTTGGTTCCCGGTTTACCAGAGAATGGAGGTATAAGATCCAAGAT This study
oNB312 ATCTTGGATCTTATACCTCCATTCTCTGGTAAACCGGGAACCAAACCAGGGC This study
Amplifies MA4421 chromosomal 
region
oNB274 GACCTTCTGGTGGATTGTTG This study
oNB318 GCAAAGCTTGTATACAGGGCAG This study
oNB319 CTCGGAAGCATGGTCTATCC This study
Amplifies uidA from pJK026A oNB369 CATATGTTACGTCCTGTAGAAACCCCAACCCG This study
oNB370 CCATGGTACGTCCTGTAGAAACCCCAACCCG This study
oNB371 GGATCCTCATTGTTTGCCTCCCTGCTGCGG This study
oNB372 GGATCCTTTTGTTTGCCTCCCTGCTGCGGTT This study
pNB723 insert sequencing oNB301 GGCTGGCTTAACTATGCGGCATC This study
oNB302 GCACCGTGGGTTTATATTCGGTCATGAGAATC This study
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Purpose Name Sequence (5’-3’) Reference
pNB730 MCS insert sequencing oNB303 CGTCAGGGCGCGTCATTAACTACT This study
att integration of pNB730 at the 
hpt locus
ϕC31 screenall#1 GAAGCTTCCCCTTGACCAAT [59]
ϕC31 screen-C2A#1 TTGATTCGGATACCCTGAGC [59]
ϕC31 screen- pJK200#1 GCAAAGAAAAGCCAGTATGGA [59]
oNB317 GATGAGTGGCAGGGCGGGGCGTAAT This study
Thrombin-cleavable tagged protein Strep-His-Thrombin ATTAAGGAGGAAATTCATATG
TGGAGCCACCCTCAGTTCGAGA
AACA TCACCATCACCATCATCA
CCATCTGGTGCCGCGTGGCTCT
TCCATGGAAGGCGCGCCGGA TC
CAAGCTTGGGCCCTCG
This study
His-Thrombin ATTAAGGAGGAAATTCATATGC
ATCACCATCACCATCATCACCA
TCT GGTGCCGCGTGGCTCTTCC
ATGGAAGGCGCGCCGGATCCA
AGCTTGGGCCCTCG
This study
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Table 3
Plasmids used in this study
Name Features Purpose Reference
pNEB193 pUC19 ori, bla +, lacZ+ Parent vector New England Biolabs
pMP44 oriR6K, bla+, Pmcr (M. barkeri) hpt, Pmcr (M. voltae) pac Gene deletion by homologous recombination (markerless)
[58]
pJK026A oriV, repE, sopABC, cat, ϕC31 attB, Pmcr (M. voltae) 
pac-hpt, PmcrB uidA
Gene insertion into ϕC31 attP site on the 
chromosome
[59]
pMS86 pac (opt) synthesized This study
pMS66 hpt (opt) synthesized This study
pNB716 strep-his MCS his-strep expression cassette synthesized This study
pNB721 pUC19 ori, bla +, lacZ+, pac (opt) Promotorless pac (opt) for conditional 
essentiality test of promoters in M. acetivorans
This study
pNB722 pUC19 ori, bla +, lacZ+, PmcrB(M. voltae) pac (opt) pac (opt) vector for homologous recombination 
repair of mutants, KO by homologous 
recombination (marked) in M. acetivorans
This study
pNB723 pUC19 ori, bla +, lacZ+, Pmcr (M. voltae) pac- hpt Gene deletion by homologous recombination (markerless) in M. acetivorans
This study
pNB724 pUC19 ori, bla +, lacZ+, PmcrB(M. voltae) pac (opt) pac (opt) vector for homologous recombination 
repair of mutants, gene deletion by homologous 
recombination (marked) (unique SpeI restriction 
site) in M. acetivorans
This study
pNB727 pUC19 ori, bla +, lacZ+, ϕC31 attB, PmcrB(M. voltae) 
pac (opt)
operon insertion into ϕC31 attP site on the 
chromosome
This study
pNB729 pUC19 ori, bla +, lacZ+, ϕC31 attB, PmcrB(M. voltae) 
pac (opt), strep-his MCS his-strep expression 
cassette
Expression of native or tagged protein in M. 
acetivorans
This study
pNB730 pUC19 ori, bla +, lacZ+, ϕC31 attB, PmcrB(M. voltae) 
pac (opt), strep-his MCS his-strep expression 
cassette
Expression of native or tagged protein (unique 
BamHI restriction site) in M. acetivorans
This study
pALD1 pUC19 ori, bla +, lacZ+, PmcrB(M. voltae) pac- hpt, 
ΔMA4421 deletion fusion
MA4421 deletion by homologous recombination 
(markerless) in M. acetivorans
This study
pSK1 pUC19 ori, bla +, lacZ+, ϕC31 attB, PmcrB(M. voltae) 
pac (opt), uidA
Expresses native UidA in M. acetivorans This study
pSK2 pUC19 ori, bla +, lacZ+, ϕC31 attB, PmcrB(M. voltae) 
pac (opt), strep-his- uidA-his-strep
Expresses strep-his-UidA-his-strep protein in M. 
acetivorans
This study
pNB735 pUC19 ori, bla +, lacZ+, ϕC31 attB, PmcrB(M. voltae) 
pac (opt), strep-his (thrombin) MCS his-strep 
expression cassette
Expression of native or tagged protein in M. 
acetivorans. Amino-terminal strep-his tag is 
cleavable with thrombin protease.
This study
pNB737 pUC19 ori, bla +, lacZ+, ϕC31 attB, PmcrB(M. voltae) 
pac (opt), his (thrombin) MCS his-strep expression 
cassette
Expression of native or tagged protein in M. 
acetivorans. Amino-terminal his tag is cleavable 
with thrombin protease.
This study
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